4-(4,6-Dichloropyrimidin-2-yl)morpholine → 1-(4-(6-Chloro-2-morpholinopyrimidin-4-yl)phenyl)-3-ethylurea
반응식
[Cl:1][C:2]1[N:7]=[C:6]([N:8]2[CH2:13][CH2:12][O:11][CH2:10][C@@H:9]2C)[N:5]=[C:4]([C:15]2[CH:20]=[CH:19][C:18]([NH:21][C:22]([NH:24][CH2:25][CH3:26])=[O:23])=[CH:17][CH:16]=2)[CH:3]=1.ClC1C=C(Cl)N=C(N2CCOCC2)N=1>>[Cl:1][C:2]1[N:7]=[C:6]([N:8]2[CH2:9][CH2:10][O:11][CH2:12][CH2:13]2)[N:5]=[C:4]([C:15]2[CH:16]=[CH:17][C:18]([NH:21][C:22]([NH:24][CH2:25][CH3:26])=[O:23])=[CH:19][CH:20]=2)[CH:3]=1참가 물질
3
실험 절차
Method as described for Intermediate 2 using 4-(4,6-dichloropyrimidin-2-yl)morpholine.
출처 및 근거
- ORD 기록
- ord-78be874bfe2f4afb901cf5dbd6f535c8
- 출처 데이터셋
- uspto-grants-2016_02
- 특허 번호
- US09249129B2
반응 노트
불러오는 중…